HARRIER CAGATAY: Open Payments
NPI 1508916461 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 48 payments from 6 companies in 2025. Trend: 2023 $918 · 2024 $1,536 · 2025 $1,374
Food & beverage: $1,374
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $750 |
| Boston Scientific Corporation | 13 | $545 |
| Averitas Pharma Inc. | 1 | $26 |
| Curonix LLC | 1 | $21 |
| Valinor Pharma, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: QULIPTA, WaveWriter Alpha Prime 16, BOTOX, General - Pain Management, QUTENZA, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, UBRELVY, MOVANTIK.
Industry payments across CA — which companies pay providers there.
